| PERIOD ENDING | 28-Feb-09 | 29-Feb-08 | 28-Feb-07 | | Total Revenue | 66,479 | 91,968 | 132,191 | | Cost of Revenue | 5,331 | 6,229 | 6,386 | | | Gross Profit | 61,148 | 85,740 | 125,805 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 284 | 728 | 766 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 60,864 | 85,011 | 125,039 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (333,286) | (152,897) | (6,187) | | Earnings Before Interest And Taxes | 60,864 | 85,011 | 87,191 | | Interest Expense | 5,714 | 15,122 | 15,560 | | Income Before Tax | 55,150 | 69,889 | 71,630 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (278,136) | (83,007) | 103,292 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (278,136) | (83,007) | 103,292 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($278,136) | ($83,007) | $103,292 |
|
1.23% Nasdaq 
Income Statement
